Liontrust Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12M | Buy |
26,954
+12,911
| +92% | +$5.75M | 0.17% | 91 |
|
|
2025
Q1 | $6.81M | Sell |
14,043
-3,986
| -22% | -$1.93M | 0.11% | 114 |
|
|
2024
Q4 | $7.26M | Buy |
18,029
+2,029
| +13% | +$817K | 0.11% | 112 |
|
|
2024
Q3 | $7.5M | Hold |
16,000
| – | – | 0.11% | 105 |
|
|
2024
Q2 | $7.5M | Buy |
16,000
+3,500
| +28% | +$1.64M | 0.11% | 105 |
|
|
2024
Q1 | $5.23M | Sell |
12,500
-500
| -4% | -$209K | 0.07% | 125 |
|
|
2023
Q4 | $5.29M | Buy |
+13,000
| New | +$5.29M | 0.08% | 117 |
|
|
2023
Q2 | – | Sell |
-2,955
| Closed | -$931K | – | 219 |
|
|
2023
Q1 | $931K | Buy |
+2,955
| New | +$931K | 0.01% | 179 |
|
|
2022
Q4 | – | Sell |
-10,640
| Closed | -$3.08M | – | 246 |
|
|
2022
Q3 | $3.08M | Hold |
10,640
| – | – | 0.05% | 167 |
|
|
2022
Q2 | $3M | Buy |
+10,640
| New | +$3M | 0.04% | 177 |
|